If you are diagnosed with stage III colon cancer, you will probably receive about six months of treatment with FOLFOX after surgery. Research shows that this treatment regimen helps prevent recurrence for some – but not all – patients with stage III colon cancer. A clinical trial has been launched to answer two questions about this current standard of care:
1. Will recurrence rates go down if both FOLFOX and celecoxib (a non-steroidal anti-inflammatory drug similar to aspirin) are used for treatment?
2. Will recurrence rates stay the same and long term side effects decrease if FOLFOX is used for three months?